Physician

James Thompson Mcclain, M.D.

According to 2025 Medicare claims, James Mcclain, M.D. (NPI: 1528320918) practices hematology/oncology in the Greenville-Anderson-Greer, SC market, with the plurality of this provider's patient population coming from Anderson, SC. This provider's primary affiliated billing organization is ANDERSON ONCOLOGY-HEMATOLOGY CLINIC PA (NPI: 1316914161; TIN: 570749974) and primary practice location at 29621-1580. Mcclain is affiliated with the Coastal Plains Network, LLC (ACO ID: A2684), participating under the MSSP model.

Mcclain's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 460 traditional Medicare patients, billed 311,480 HCPCS/CPT codes, and received $5,974,825 in Medicare payments. The top billing code was 82728 (Ferritin (blood protein) level). Part D data shows 1,672 prescription claims across 330 beneficiaries totaling $5,525,259 in drug costs, led by Tagrisso (Osimertinib Mesylate). DME data shows 11 claims. Open Payments data shows 212 records totaling $5,004. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $500,397 to $5,974,825. Similarly, Part D prescription costs have moved sharply higher in recent years, from $90,526 to $5,525,259. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	347	106,944	$500,397
2019	416	339,169	$2,900,914
2020	391	337,701	$3,828,242
2021	414	352,809	$4,169,412
2022	426	311,013	$4,436,139
2023	443	326,882	$5,523,104
2024	460	311,480	$5,974,825

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	78	801	$90,526
2016	59	135	$109,638
2017	69	183	$127,819
2018	114	290	$384,838
2019	179	1,083	$1,960,595
2020	188	1,033	$2,774,017
2021	251	1,494	$2,953,538
2022	250	1,334	$3,988,553
2023	283	1,447	$4,732,688
2024	330	1,672	$5,525,259

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	14	$261
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	27	$4,734
2020	N/R	64	$5,781
2021	N/R	45	$3,334
2022	N/R	15	$1,019
2023	N/R	N/R	N/R
2024	N/R	11	$1,797

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
82728	Ferritin (blood protein) level	316	623	$13
80053	Blood test, comprehensive group of blood chemicals	434	1,612	$10
83550	Iron binding capacity	318	619	$8
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	436	2,015	$8
83540	Iron level	316	620	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tagrisso	Osimertinib Mesylate	51	1,530	$860,635
Calquence	Acalabrutinib Maleate	64	1,920	$812,562
Brukinsa	Zanubrutinib	48	1,440	$671,870
Ayvakit	Avapritinib	14	420	$537,481
Ibrance	Palbociclib	26	728	$399,803

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4152	Enteral formula, nutritionally complete, calorically dense (equal to or greater than 1.5 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	11	$1,797

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	212	$5,004	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for James Thompson Mcclain, M.D.?

Tedicare shows public-source Medicare data for James Thompson Mcclain, M.D. (NPI 1528320918), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James Thompson Mcclain, M.D. have ACO affiliation data?

James Thompson Mcclain, M.D. is shown with ACO affiliation data for Coastal Plains Network, LLC (MSSP, ACO ID A2684).

What billing organization is linked to James Thompson Mcclain, M.D.?

James Thompson Mcclain, M.D. is linked to ANDERSON ONCOLOGY-HEMATOLOGY CLINIC PA (billing NPI 1316914161) in the available physician profile data.

Does James Thompson Mcclain, M.D. have Open Payments data?

James Thompson Mcclain, M.D. has 212 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.